# Study of PHN131 in Patients After Surgery

> **NCT02193620** · PHASE2,PHASE3 · COMPLETED · sponsor: **PhytoHealth Corporation** · enrollment: 106 (actual)

## Conditions studied

- Analgesia Disorder

## Interventions

- **DRUG:** PHN131 soft capsule with Nalbuphine HCl 60 mg/cap
- **DRUG:** Placebo soft capsules
- **DRUG:** Dicofenac

## Key facts

- **NCT ID:** NCT02193620
- **Lead sponsor:** PhytoHealth Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04-30
- **Primary completion:** 2014-09-21
- **Final completion:** 2019-02-13
- **Target enrollment:** 106 (ACTUAL)
- **Last updated:** 2025-06-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02193620

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02193620, "Study of PHN131 in Patients After Surgery". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02193620. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*